Global Huntington's Disease Therapeutics Market 2017-2021

Publisher Name :
Date: 02-Aug-2017
No. of pages: 86
Inquire Before Buying

HD is an inherited condition that leads to destruction of nerve cells or neurons. The damage to nerve cells usually causes change in personality, mood swings, irritability and altered behavior. The global HD therapeutics market was witnessing a high unmet demand for disease modifying drug, in the presence of only one approved therapy, Xenazine, and the off-label use of various different therapeutics. The introduction of AUSTEDO in the market will have a significant impact on the market growth, thereby changing the market dynamics.

The analysts forecast global huntington's disease therapeutics market to grow at a CAGR of 14.75% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global huntington's disease therapeutics market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off label drugs.

The market is divided into the following segments based on geography:


  • Americas

  • APAC

  • EMEA


This report, Global Huntington's Disease Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


  • F. Hoffmann-La Roche

  • H. Lundbeck

  • Prana Biotechnology

  • Teva Pharmaceutical Industries


Other prominent vendors


  • Intellect Neurosciences

  • Horizon Pharma

  • Sangamo Therapeutics

  • Vertex Pharmaceuticals


Market driver


  • Early onset of disease symptoms, increases the demand for HD therapeutics

  • For a full, detailed list, view our report


Market challenge


  • Increase in alternative programs for management of mental disorders

  • For a full, detailed list, view our report


Market trend


  • Advances in biomedical sciences

  • For a full, detailed list, view our report


Key questions answered in this report


  • What will the market size be in 2021 and what will the growth rate be?

  • What are the key market trends?

  • What is driving this market?

  • What are the challenges to market growth?

  • Who are the key vendors in this market space?

Global Huntington's Disease Therapeutics Market 2017-2021

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
Market outline

PART 05: HD: An introduction

PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 07: Pipeline

PART 08: Market segmentation by drug-class
Market scenario by drug-class
Antidopaminergics
Anticonvulsants
Antipsychotics
Antidepressants
Others

PART 09: Geographical segmentation
Market segmentation by geography
HD therapeutics market in Americas
HD therapeutics market in EMEA
HD therapeutics market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
Market drivers
Market challenges

PART 12: Market trends
Advances in biomedical sciences
Focus on regenerative therapies for mental disorders
Rising public interest toward mental health

PART 13: Vendor landscape
Competitive scenario

PART 14: Key vendor analysis
F. Hoffmann-La Roche
H. Lundbeck
Prana Biotechnology
Teva Pharmaceutical Industries
Other prominent vendors

PART 15: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Parts of brain affected by HD
Exhibit 02: Key facts about HD
Exhibit 03: Prevalence and incidence of HD
Exhibit 04: Neurotransmitter involved in pathogenesis of HD
Exhibit 05: Market snapshot
Exhibit 06: Global HD therapeutics market 2016-2021 ($ millions)
Exhibit 07: Opportunity analysis of global HD therapeutics market
Exhibit 08: Five forces analysis
Exhibit 09: Pipeline landscape based on number of molecules 2016
Exhibit 10: HD: Key clinical trials
Exhibit 11: Segmentation of global HD therapeutics market by drug-class
Exhibit 12: Global HD therapeutics market share by drug-class
Exhibit 13: Antidopaminergics used in HD
Exhibit 14: Uses and side-effects of antidopaminergics
Exhibit 15: Global HD therapeutics market by antidopaminergics 2016-2021 ($ millions)
Exhibit 16: Pharmacologic approach for the treatment of chorea
Exhibit 17: Anticonvulsants used in HD
Exhibit 18: Uses and side-effects of anticonvulsants
Exhibit 19: Global HD therapeutics market by anticonvulsants 2016-2021 ($ millions)
Exhibit 20: Antipsychotics used in HD
Exhibit 21: Uses and side-effects of antipsychotics
Exhibit 22: Global HD therapeutics market by antipsychotics 2016-2021 ($ millions)
Exhibit 23: Symptoms of depression associated with HD
Exhibit 24: Global HD therapeutics market by antidepressants 2016-2021 ($ millions)
Exhibit 25: Symptoms of mania associated with HD
Exhibit 26: Global HD therapeutics market share by geography 2016 and 2021
Exhibit 27: Global HD therapeutics market revenue by geography 2016-2021
Exhibit 28: Global HD therapeutics market share by geography 2016-2021
Exhibit 29: HD therapeutics market scenario in different geographies
Exhibit 30: Market scenario in Americas
Exhibit 31: HD therapeutics market in Americas 2016-2021 ($ millions)
Exhibit 32: Market scenario in EMEA
Exhibit 33: HD therapeutics market in EMEA 2016-2021 ($ millions)
Exhibit 34: Market scenario in APAC
Exhibit 35: HD therapeutics market in APAC 2016-2021 ($ millions)
Exhibit 36: Planned clinical trials of iPS cell-based therapies
Exhibit 37: Competitive structure analysis of global HD therapeutics market 2016
Exhibit 38: F. Hoffmann-La Roche: Key highlights
Exhibit 39: F. Hoffmann-La Roche: Strength assessment
Exhibit 40: F. Hoffmann-La Roche: Strategy assessment
Exhibit 41: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 42: H. Lundbeck: Key highlights
Exhibit 43: H. Lundbeck: Strength assessment
Exhibit 44: H. Lundbeck: Strategy assessment
Exhibit 45: H. Lundbeck: Opportunity assessment
Exhibit 46: Prana Biotechnology: Key highlights
Exhibit 47: Prana Biotechnology: Strength assessment
Exhibit 48: Prana Biotechnology: Strategy assessment
Exhibit 49: Prana Biotechnology: Opportunity assessment
Exhibit 50: Teva Pharmaceuticals: Key highlights
Exhibit 51: Teva Pharmaceuticals: Strength assessment
Exhibit 52: Teva Pharmaceuticals: Strategy assessment
Exhibit 53: Teva Pharmaceuticals: Opportunity assessment

  • Global Huntington's Disease Partnering 2012 to 2018
    Published: 01-Mar-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Huntington's Disease Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provide......
  • Huntington's Disease - Epidemiology Forecast to 2027
    Published: 31-Jan-2018        Price: US 3250 Onwards        Pages: 50
    DelveInsight's "Huntington's Disease - Epidemiology Forecast, 2027" report provides a comprehensive analysis of the Huntington's Disease epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2027 Huntington's Disease Epidemiology The epidemiology......
  • Huntington's Disease - Market Insight, Epidemiology and Market Forecast - 2027
    Published: 31-Jan-2018        Price: US 6250 Onwards        Pages: 100
    DelveInsight's "Huntington's Disease - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Huntington's Disease epidemiology and market outlook for the 7MM. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2027 Huntington's Disease Understanding and Treatment Algorithm The market report provides the overvi......
  • Huntington Disease - Pipeline Review, H2 2017
    Published: 21-Dec-2017        Price: US 2000 Onwards        Pages: 287
    Huntington Disease - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease - Pipeline Review, H2 2017, provides an overview of the Huntington Disease (Central Nervous System) pipeline landscape. Huntington's disease (HD) is an inherited disease that causes certain nerve cells in the brain to waste away. HD is a familial disease that is passed on from parent to child throug......
  • Global Huntington's Disease Partnering 2010 to 2017
    Published: 01-Nov-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Huntington's Disease Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provide......
  • Huntingtin (Huntington Disease Protein or HTT) - Pipeline Review, H2 2017
    Published: 31-Oct-2017        Price: US 3500 Onwards        Pages: 60
    According to the recently published report 'Huntingtin - Pipeline Review, H2 2017'; Huntingtin (Huntington Disease Protein or HTT) pipeline Target constitutes close to 16 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes.Huntingtin (Huntington Disease Protein or HTT) - Huntingtin protein is an encoded by the huntingtin gene, also called the HTT or HD (Huntington disease) gene. Huntingtin up regulates the expression of br......
  • Huntington Disease - Pipeline Review, H1 2017
    Published: 13-Jun-2017        Price: US 2000 Onwards        Pages: 299
    Huntington Disease - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease - Pipeline Review, H1 2017, provides an overview of the Huntington Disease (Central Nervous System) pipeline landscape. Huntington's disease (HD) is an inherited disease that causes certain nerve cells in the brain to waste away. HD is a familial disease that is passed on from parent to child throug......
  • Huntington Disease - Pipeline Review, H2 2016
    Published: 14-Dec-2016        Price: US 2000 Onwards        Pages: 292
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease - Pipeline Review, H2 2016, provides an overview of the Huntington Disease (Central Nervous System) pipeline landscape.Huntington's disease (HD) is an inherited disease that causes certain nerve cells in the brain to waste away. HD is a familial disease that is passed on from parent to child through a mutation in their genes. Early symptoms of HD include uncontrolled movements, clumsiness, a......
  • Global Huntington's Disease Therapeutics Sales Market Report 2016
    Published: 09-Nov-2016        Price: US 4000 Onwards        Pages: 126
    Notes: Sales, means the sales volume of Huntington's Disease Therapeutics Revenue, means the sales value of Huntington's Disease Therapeutics This report studies sales (consumption) of Huntington's Disease Therapeutics in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Auspex Pharmaceutica......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs